2018 Synthetic Biology: Engineering, Evolution & Design (SEED)

SEED 2018 will focus on advances in science, technology, applications, and related investments in the field of synthetic biology. This year's theme will be "synthetic biology at the leading edge of massive DNA synthesis, editing, and decoding.”
Here, synthetic biology will be broadly defined as cellular and biochemical technologies for accelerating bioengineering that are enabled by radical advances in DNA writing and reading. The conference will highlight recent discoveries and new tools that are positioned at the leading edge of rapid, massive DNA synthesis and editing. In addition, presentations and discussions will feature the use of synthetic biology to broadly enable biotechnology applications, including therapeutics, industrial chemicals and fuels, natural products, and agriculture.
The Call for Posters is still open.
Keynote Speakers:
- James Collins, Massachusetts Institute of Technology
- Jay Keasling, University of California, Berkeley
- Floyd E. Romesberg, The Scripps Research Institute
- Pamela Ronald, University of California, Davis
View additional confirmed speakers
Chairs:
- Karmella Haynes, Arizona State University
- Ryan Gill, University of Colorado Boulder
Topic Sessions:
There will be ten topic sessions under three major tracks.
Science
- Reverse Engineering of Biological Systems
- Forward Engineering of Biological Systems
- Biological Frontiers: Newly Explored Systems
Technology
- Automation Technologies for Synthetic Biology
- DNA Writing and Assembly
- Engineering Functional Genomes
Applications
- Biological Frontiers: Newly Enabled Applications
- Biology-Inspired Materials
- Industrial Biotechnology
- Human Health
Highlights
Mummy Mountain Reception
Software for Synthetic Biology Workflows Workshop
Featured Speakers
James Collins
James J. Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. His research group focuses on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance. His patented technologies have been licensed by over 25 companies.Read more